[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Mundipharma (China) Pharmaceutical Co. Ltd\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":20,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100659983","real-world-study-of-the-effectiveness-and-tolerability-of-outpatient-titration-of-oxycontin-for-the-moderate-and-severe-pain-in-cancer-patients-100659983",false,"NCT07869797","Real-world Study of the Effectiveness and Tolerability of Outpatient Titration of OxyContin for the Moderate and Severe Pain in Cancer Patients","Inclusion Criteria:\n\n* Male or female cancer participants, age ≥ 18 years\n* Participants presenting with moderate to severe (NRS ≥ 4 points) cancer-related pain\n* Participants undergoing outpatient titration regimen with OxyContin as background, see Appendix 3\n* Voluntarily sign an informed consent form\n\nExclusion Criteria:\n\n* Participants with cognitive impairment, delirium, psychiatric disorders, or other conditions that may interfere with reliable pain self-assessment\n* Participants are receiving surgery or minimally invasive interventional pain management\n* Participants are not willing to cooperate in completing follow-up\n* The investigator judges as unsuitable for inclusion in the study","ALL","18 Years",{"count":18,"type":19},378,"ESTIMATED","8 Days","OBSERVATIONAL","The purpose of this observational study is to evaluate the effectiveness and tolerability of outpatient titration regimen with OxyContin as background for moderate and severe pain in cancer patients in adult patients with moderate to severe cancer pain. The main questions it aims to answer are\n\n* To evaluate the effectiveness of titration regimen with OxyContin as background for the moderate and severe pain in cancer participants\n* To explore the tolerability of titration regimen with OxyContin as background use in outpatient participants with moderate and severe cancer pain",[24],"Cancer Pain",[26,27,28,29],"moderate and severe pain in cancer patients","outpatient titration of OxyContin","Real-world study","effectiveness and tolerability","NOT_YET_RECRUITING","2026-10-07",{"date":33,"type":34},"2026-10-13","ACTUAL",{"date":36,"type":19},"2026-10",{"date":38,"type":19},"2027-04",{"name":40,"class":41},"Mundipharma (China) Pharmaceutical Co. Ltd","INDUSTRY",20,""]